Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Upcoming Conference in Federal Pradaxa Bleeding Litigation

Share Article

The Pradaxa lawyers at Bernstein Liebhard LLP are now investigating legal claims on behalf of alleged victims of Pradaxa bleeding.

Free Case Review
Pradaxa lawsuits continue to be evaluated by our Firm, as we regularly hear from individuals who suffered serious and frightening episodes of internal bleeding, allegedly due to their use of this blood thinner.

A growing number of Pradaxa lawsuits ( filed on behalf of people who allegedly suffered life-threatening episodes of internal bleeding due to their use of the blood thinner continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, a Status Conference will be convened in the Pradaxa bleeding litigation on Tuesday, October 8th, at 9:30 a.m. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“Pradaxa lawsuits continue to be evaluated by our Firm, as we regularly hear from individuals who suffered serious and frightening episodes of internal bleeding, allegedly due to their use of this blood thinner,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s Pradaxa lawyers are currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Bleeding Litigation
According to court documents, 1,579 Pradaxa lawsuits are currently pending in the multidistrict litigation underway in the Southern District of Illinois. The lawsuits accuse Boehringer Ingelheim, the manufacturer of Pradaxa, of marketing the blood thinner despite knowing that the drug could cause dangerous and potentially fatal hemorrhaging in some patients. Plaintiffs further allege that the company failed to provide adequate warnings to doctors and patients regarding the lack of a readily available antidote to reverse Pradaxa bleeding.

According to a recent report, Pradaxa has been the subject of regulatory warnings in several countries since it first came on the U.S. market in October 2010. Most of these warnings have been prompted by the drug’s association with internal bleeding, a known Pradaxa side effect for which there exists no readily available reversal agent. While it was touted as an improvement over warfarin, the hemorrhaging that is sometimes associated with that decades-old blood thinner can be staunched with the administration of vitamin K.* In January, the Institute for Safe Medicine Practices (ISMP), reported that data from the U.S. Food & Drug Administration indicated that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.

Alleged Pradaxa bleeding victims may be eligible to file a lawsuit against Boehringer Ingelheim to obtain compensation for their medical bills, lost wages, pain and suffering, and more. Click Here to contact a Pradaxa lawyer at Bernstein Liebhard LLP. To arrange for a free legal consultation, please call 800-511-5092.

*,, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website